Form D · Biotechnology
Nano Terra, Inc.
Cambridge, MA · CIK 0001507409
Offering snapshot reported Oct 23, 2014 · SEC filing
- Reported sold
- $6.39M Offering amount: $8M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 8, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 23, 2014 | Initial | $6,388,098 | No comparison | 9 | SEC filing |
| Apr 25, 2011 | Initial | $2,300,069 | No comparison | 1 | SEC filing |
| Dec 13, 2010 | Initial | $17,227,966 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-226995
Source: Form D, filed Oct 23, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Myer Berlow | Director |
| Peter Howe | Executive |
| Eric Keller | Executive |
| Brian Mayers | Executive |
| Ueli Morant | Director, Executive |
| Carmichael Roberts | Director |
| George Whitesides | Director |
| Herbert Winokur | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
737 Concord Avenue
Cambridge, MA, 02138
Cambridge, MA, 02138